Press Releases
Nov 26, 2024
Satsuma Pharmaceuticals and SNBL Receive FDA Acceptance of NDA Resubmission of STS101 for the Acute Treatment of Migraine With or Without Aura
Oct 31, 2024
Innovative
Therapeutics for
Better Health
Because Life
Shouldn't Have to
Wait for Migraines